Dimitri G. Trembath
YOU?
Author Swipe
View article: An <i>ex vivo</i> functional biomarker of treatment response in pediatric low-grade glioma
An <i>ex vivo</i> functional biomarker of treatment response in pediatric low-grade glioma Open
Background Children with subtotally resected pediatric low-grade glioma (pLGG) often face multiple lines of treatment, which are seldom capable of eliminating the entire tumor. Genomics-based biomarkers are often used to select targeted th…
View article: Purity Independent Subtyping of Tumors (PurIST) Pancreatic Cancer Classifier
Purity Independent Subtyping of Tumors (PurIST) Pancreatic Cancer Classifier Open
View article: Colonic epithelial miR-31 associates with the development of Crohn's phenotypes
Colonic epithelial miR-31 associates with the development of Crohn's phenotypes Open
BACKGROUND: Crohn's disease (CD) is highly heterogeneous, due in large part to variability in cellular processes that underlie the natural history of CD, thereby confounding effective therapy. There is a critical need to advance understand…
View article: Endoscopic ultrasound-guided fine needle biopsy through the interstices of a colonic stent for the diagnosis of metastatic breast cancer using a forward-viewing linear echoendoscope
Endoscopic ultrasound-guided fine needle biopsy through the interstices of a colonic stent for the diagnosis of metastatic breast cancer using a forward-viewing linear echoendoscope Open
Malignancies of extracolonic origin can be the cause of colorectal obstruction. Acute colorectal obstruction generally requires rapid decompression. Self-expandable metal stent (SEMS) placement is a nonsurgical alternative for palliation o…
View article: Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
ECT2 is an activator of RHO GTPases that is essential for cytokinesis. In addition, ECT2 was identified as an oncoprotein when expressed ectopically in NIH/3T3 fibroblasts. However, oncogenic activation of ECT2 resulted from N-terminal tru…
View article: Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma Open
Clinical trials of combined IDO/PD1 blockade in metastatic melanoma (MM) failed to show additional clinical benefit compared to PD1-alone inhibition. We reasoned that a tryptophan-metabolizing pathway other than the kynurenine one is essen…
View article: Supplementary Figures from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Supplementary Figures from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
Supplementary Figures S1-S4
View article: Supplementary Figures from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Supplementary Figures from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
Supplementary Figures S1-S4
View article: Supplementary Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Supplementary Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
Supplementary Tables and Methods.
View article: Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
ECT2 is an activator of RHO GTPases that is essential for cytokinesis. In addition, ECT2 was identified as an oncoprotein when expressed ectopically in NIH/3T3 fibroblasts. However, oncogenic activation of ECT2 resulted from N-terminal tru…
View article: Supplementary Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Supplementary Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
Supplementary Tables and Methods.
View article: Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Data from Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
ECT2 is an activator of RHO GTPases that is essential for cytokinesis. In addition, ECT2 was identified as an oncoprotein when expressed ectopically in NIH/3T3 fibroblasts. However, oncogenic activation of ECT2 resulted from N-terminal tru…
View article: Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases Open
View article: Increased Tryptophan, But Not Increased Glucose Metabolism, Predict Resistance of Pembrolizumab in Stage III/IV Melanoma
Increased Tryptophan, But Not Increased Glucose Metabolism, Predict Resistance of Pembrolizumab in Stage III/IV Melanoma Open
Clinical trials of combined IDO/PD1 blockade in metastatic melanoma (MM) failed to show additional clinical benefit compared to PD1-alone inhibition. We reasoned that a tryptophan-metabolizing pathway other than the kynurenine one is essen…
View article: Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors
Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors Open
Context.— Integration of molecular data into glioma classification supports diagnostic, prognostic, and therapeutic decision-making; however, testing practices for these informative biomarkers in clinical laboratories remain unclear. Objec…
View article: The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma Open
View article: Rectal carcinoma arising in a patient with intestinal and hepatic schistosomiasis due to Schistosoma mekongi
Rectal carcinoma arising in a patient with intestinal and hepatic schistosomiasis due to Schistosoma mekongi Open
Schistosomiasis is a parasitic trematode infection spread by snails with multiple species causing human disease. Infection can cause liver disease, including fibrosis and portal hypertension, and has been linked to malignancies such as bla…
View article: Additional file 2 of The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
Additional file 2 of The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma Open
Additional file 2. Individual Patient Data for the UNC-CH/Vanderbilt/California Pacific Medical Research Institute. Abbreviations: F, female; M, male; MM, metastatic melanoma; f/u, follow-up; immunotx, immunotherapy; n/a, non applicable; n…
View article: Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth
Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth Open
ECT2 is an activator of RHO GTPases that is essential for cytokinesis. In addition, ECT2 was identified as an oncoprotein when expressed ectopically in NIH/3T3 fibroblasts. However, oncogenic activation of ECT2 resulted from N-terminal tru…
View article: Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer Open
The five-year survival rate for metastatic pancreatic cancer is currently only 3%, which increases to 13% with local invasion only and to 39% with localized disease at diagnosis. Here we evaluated repurposed mebendazole, an approved anthel…
View article: Melanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases
Melanoma-specific expression of the tumor suppressor proteins p16 and PTEN is a favorable prognostic factor in established melanoma brain metastases Open
PTEN and p16 frequently undergo (epi)genetic aberrations in melanoma resulting in decreased, or absent, protein levels. We investigated the prognostic significance of these tumor suppressor genes in melanoma brain metastases (MBMs). Immuno…
View article: Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases Open
Background High tumor-infiltrating lymphocytes (TILs) and hemorrhage are important prognostic factors in patients who have undergone craniotomy for melanoma brain metastases (MBM) before 2011 at the University of Pittsburgh Medical Center …
View article: MERTK receptor tyrosine kinase is a therapeutic target in melanoma
MERTK receptor tyrosine kinase is a therapeutic target in melanoma Open
Metastatic melanoma is one of the most aggressive forms of cutaneous cancers. Although recent therapeutic advances have prolonged patient survival, the prognosis remains dismal. C-MER proto-oncogene tyrosine kinase (MERTK) is a receptor ty…
View article: Current Developments in the Genetics of Autism: From Phenome to Genome
Current Developments in the Genetics of Autism: From Phenome to Genome Open
Despite compelling evidence from twin and family studies indicating a strong genetic involvement in the etiology of autism, the unequivocal detection of autism susceptibility genes remains an elusive goal. The purpose of this review is to …
View article: MicroRNAs Classify Different Disease Behavior Phenotypes of Crohnʼs Disease and May Have Prognostic Utility:
MicroRNAs Classify Different Disease Behavior Phenotypes of Crohnʼs Disease and May Have Prognostic Utility: Open
Article first published online 6 July 2015.Supplemental Digital Content is Available in the Text.Background:There is a dire need for reliable prognostic markers that can guide effective therapeutic intervention in Crohn's disease (CD). We …
View article: Detection of Dysplasia in Barrett's Esophagus With In Vivo Depth-Resolved Nuclear Morphology Measurements
Detection of Dysplasia in Barrett's Esophagus With In Vivo Depth-Resolved Nuclear Morphology Measurements Open
Patients with Barrett’s esophagus (BE) show increased risk for developing esophageal adenocarcinoma and are routinely examined using upper endoscopy with biopsy to search for neoplastic changes. Angle-resolved low coherence interferometry …
View article: Olfactory neuroblastoma pulmonary metastasis presenting as a solitary pulmonary mass in an adult: A case report with pathologic correlation
Olfactory neuroblastoma pulmonary metastasis presenting as a solitary pulmonary mass in an adult: A case report with pathologic correlation Open
View article: Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumors Open
Desmoplastic small round cell tumors (DSRCTs) are highly aggressive sarcomas that most commonly occur intra‐abdominally, and are defined by EWSR1 ‐ WT1 gene fusion. Intracranial DSRCTs are exceptionally rare with only seven previously repo…
View article: Metastatic melanoma in an esophagus demonstrating Barrett esophagus with high grade dysplasia
Metastatic melanoma in an esophagus demonstrating Barrett esophagus with high grade dysplasia Open
Background Metastatic melanoma involving the esophagus is rare; the occurrence of metastatic melanoma in a background of Barrett esophagus is rarer still. We report a case of an 80 year-old male who presented to our institution for workup …